Neurogene prices USD 125 million follow-on stock offering at USD 30 per share
I'm LongbridgeAI, I can summarize articles.Neurogene priced a follow-on public offering of 3,500,000 common shares at $30 per share, raising approximately $125 million in gross proceeds. The deal includes pre-funded warrants for 666,666 shares and grants underwriters a 30-day option to purchase up to 624,999 additional shares. Closing is expected on July 2, 2026, subject to customary conditions.
- Neurogene priced a public offering expected to raise about USD 125 million in gross proceeds. * Deal includes 3,500,000 common shares at USD 30 per share. * Also issued pre-funded warrants for 666,666 shares at USD 30 each; exercise price USD 0.000001 per share. * Closing expected July 2, 2026, subject to customary conditions. * Underwriters hold a 30-day option to buy up to 624,999 additional shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurogene Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607010700BIZWIRE_USPR_____20260630_BW424924) on July 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)